Brokerages Set Select Medical Holdings Corporation (NYSE:SEM) Price Target at $19.20

Select Medical Holdings Corporation (NYSE:SEMGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the six research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $19.40.

SEM has been the subject of a number of analyst reports. UBS Group reaffirmed a “neutral” rating and issued a $14.00 target price (down previously from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Bank of America decreased their target price on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Royal Bank Of Canada raised their target price on shares of Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday.

Get Our Latest Stock Analysis on Select Medical

Select Medical Stock Down 2.5%

Shares of NYSE:SEM opened at $13.30 on Wednesday. Select Medical has a 52 week low of $11.65 and a 52 week high of $40.98. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The company has a market capitalization of $1.65 billion, a PE ratio of 12.55, a PEG ratio of 0.55 and a beta of 1.28. The company has a 50 day moving average price of $12.75 and a two-hundred day moving average price of $14.49.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.60 earnings per share. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Analysts forecast that Select Medical will post 1.17 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were paid a $0.0625 dividend. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a yield of 1.9%. Select Medical’s dividend payout ratio (DPR) is currently 23.58%.

Institutional Trading of Select Medical

Large investors have recently added to or reduced their stakes in the company. SG Americas Securities LLC lifted its stake in Select Medical by 151.0% in the first quarter. SG Americas Securities LLC now owns 37,684 shares of the health services provider’s stock valued at $629,000 after acquiring an additional 22,671 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Select Medical by 47.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 24,450 shares of the health services provider’s stock valued at $403,000 after acquiring an additional 7,871 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in Select Medical in the first quarter valued at $416,000. GAMMA Investing LLC lifted its stake in Select Medical by 217.4% in the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider’s stock valued at $109,000 after acquiring an additional 4,453 shares during the last quarter. Finally, Ritholtz Wealth Management acquired a new stake in Select Medical in the first quarter valued at $460,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.